The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Targan, S. R.
Right arrow Articles by Newman, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Targan, S. R.
Right arrow Articles by Newman, W.

The Journal of Immunology, Vol 131, Issue 3 1149-1153, Copyright © 1983 by American Association of Immunologists


ARTICLES

Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200

SR Targan and W Newman

The monoclonal antibody 13.1 recognizes an epitope on the T-200 glycoprotein and blocks natural killer (NK) lysis of the erythroleukemia target K562, but not of the acute lymphoblastic leukemia T cell target Molt-4. The inhibitory effect is at the killer cell level and not the target cell level, which suggests that 13.1 may react with a receptor on NK cells. This hypothesis was tested in assays to delineate precisely where in the NK cytolytic reaction sequence 13.1 interferes with lysis; 13.1 did not block initial NK-target cell interaction as measured in a target binding cell assay. With the use of a Ca++ pulse technique, 13.1 did not block any events occurring during Ca++-dependent programming. If the antibody was added after conjugate formation but before the addition of CaCl2 to initiate programming, however, full inhibition of NK lysis occurred. Therefore, 13.1 antibody defines a distinct stage in the NK reaction sequence that links target binding to the initiation of calcium-dependent programming events. NK cell binding alone is not sufficient to trigger lytic events, and the presence of a second structure or a distinct portion on a single structure is required to trigger lysis. We show that 13.1 blocks the ability of K562 to inhibit NK killing of Molt-4 in a cold target inhibition assay. Therefore, despite the fact that 13.1 does not disrupt conjugate formation, NK specificity may exist at a post-binding site rather than at the initial NK-target binding interaction. Our data suggest that the T-200 glycoprotein on NK cells triggers the initiation of the lytic events.


This article has been cited by other articles:


Home page
ScienceHome page
R Giorda, W. Rudert, C Vavassori, W. Chambers, J. Hiserodt, and M Trucco
NKR-P1, a signal transduction molecule on natural killer cells
Science, September 14, 1990; 249(4974): 1298 - 1300.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.